Extracellular Vesicles Secreted by Atherogenic Macrophages Transfer MicroRNA to Inhibit Cell Migration

Objective— During inflammation, macrophages secrete vesicles carrying RNA, protein, and lipids as a form of extracellular communication. In the vessel wall, extracellular vesicles (EVs) have been shown to be transferred between vascular cells during atherosclerosis; however, the role of macrophage-derived EVs in atherogenesis is not known. Here, we hypothesize that atherogenic macrophages secrete microRNAs (miRNAs) in EVs to mediate cell–cell communication and promote proinflammatory and proatherogenic phenotypes in recipient cells. Approach and Results— We isolated EVs from mouse and human macrophages treated with an atherogenic stimulus (oxidized low-density lipoprotein) and characterized the EV miRNA expression profile. We confirmed the enrichment of miR-146a, miR-128, miR-185, miR-365, and miR-503 in atherogenic EVs compared with controls and demonstrate that these EVs are taken up and transfer exogenous miRNA to naive recipient macrophages. Bioinformatic pathway analysis suggests that atherogenic EV miRNAs are predicted to target genes involved in cell migration and adhesion pathways, and indeed delivery of EVs to naive macrophages reduced macrophage migration both in vitro and in vivo. Inhibition of miR-146a, the most enriched miRNA in atherogenic EVs, reduced the inhibitory effect of EVs on macrophage migratory capacity. EV-mediated delivery of miR-146a repressed the expression of target genes IGF2BP1 (insulin-like growth factor 2 mRNA-binding protein 1) and HuR (human antigen R or ELAV-like RNA-binding protein 1) in recipient cells, and knockdown of IGF2BP1 and HuR using short interfering RNA greatly reduced macrophage migration, highlighting the importance of these EV-miRNA targets in regulating macrophage motility. Conclusions— EV-derived miRNAs from atherogenic macrophages, in particular miR-146a, may accelerate the development of atherosclerosis by decreasing cell migration and promoting macrophage entrapment in the vessel wall.

[1]  M. Cybulsky,et al.  Paradoxical Suppression of Atherosclerosis in the Absence of microRNA-146a , 2017, Circulation research.

[2]  E. Aikawa,et al.  Extracellular vesicles in cardiovascular calcification: expanding current paradigms , 2016, The Journal of physiology.

[3]  Alissa M. Weaver,et al.  KRAS-MEK Signaling Controls Ago2 Sorting into Exosomes , 2016, Cell reports.

[4]  R. Silverstein,et al.  Extracellular Vesicles Activate a CD36-Dependent Signaling Pathway to Inhibit Microvascular Endothelial Cell Migration and Tube Formation , 2016, Arteriosclerosis, thrombosis, and vascular biology.

[5]  K. Moore,et al.  MicroRNA Regulation of Atherosclerosis. , 2016, Circulation research.

[6]  Randy Schekman,et al.  Y-box protein 1 is required to sort microRNAs into exosomes in cells and in a cell-free reaction , 2016, bioRxiv.

[7]  K. Rayner,et al.  Therapeutic Inhibition of miR-33 Promotes Fatty Acid Oxidation but Does Not Ameliorate Metabolic Dysfunction in Diet-Induced Obesity , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[8]  Pardis C Sabeti,et al.  Genome-wide identification of microRNAs regulating cholesterol and triglyceride homeostasis , 2015, Nature Medicine.

[9]  Zijian Xie,et al.  Oxidized LDL–bound CD36 recruits an Na+/K+-ATPase–Lyn complex in macrophages that promotes atherosclerosis , 2015, Science Signaling.

[10]  R. Raffai,et al.  Apolipoprotein E enhances microRNA-146a in monocytes and macrophages to suppress nuclear factor-κB-driven inflammation and atherosclerosis. , 2015, Circulation research.

[11]  A. Orekhov,et al.  Extracellular vesicles and atherosclerotic disease , 2015, Cellular and Molecular Life Sciences.

[12]  Mary-Ellen Harper,et al.  Macrophage mitochondrial energy status regulates cholesterol efflux and is enhanced by anti‐miR33 in atherosclerosis , 2015, Circulation research.

[13]  S. Booth,et al.  MicroRNA-146a: A Dominant, Negative Regulator of the Innate Immune Response , 2014, Front. Immunol..

[14]  Seena K. Ajit,et al.  Functional significance of macrophage-derived exosomes in inflammation and pain , 2014, PAIN®.

[15]  Y. Suh,et al.  A common variant in pre-miR-146 is associated with coronary artery disease risk and its mature miRNA expression. , 2014, Mutation research.

[16]  F. Sánchez‐Madrid,et al.  Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs , 2013, Nature Communications.

[17]  Maarten Hulsmans,et al.  MicroRNA-containing microvesicles regulating inflammation in association with atherosclerotic disease. , 2013, Cardiovascular research.

[18]  K. Moore,et al.  Macrophages in atherosclerosis: a dynamic balance , 2013, Nature Reviews Immunology.

[19]  M. Cybulsky,et al.  MicroRNA-146 represses endothelial activation by inhibiting pro-inflammatory pathways , 2013, EMBO molecular medicine.

[20]  K. Moore,et al.  Neuroimmune Guidance Cue Semaphorin 3E Is Expressed in Atherosclerotic Plaques and Regulates Macrophage Retention , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[21]  K. Moore,et al.  Endothelial Expression of Guidance Cues in Vessel Wall Homeostasis Dysregulation Under Proatherosclerotic Conditions , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[22]  Melissa G. Piper,et al.  Macrophage microvesicles induce macrophage differentiation and miR-223 transfer. , 2013, Blood.

[23]  W. Britton,et al.  Microparticles from Mycobacteria-Infected Macrophages Promote Inflammation and Cellular Migration , 2013, The Journal of Immunology.

[24]  Mahdieh Khosroheidari,et al.  Comparison of protein, microRNA, and mRNA yields using different methods of urinary exosome isolation for the discovery of kidney disease biomarkers. , 2012, Kidney international.

[25]  M. Wood,et al.  Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy. , 2012, Human molecular genetics.

[26]  C. K. Hsiao,et al.  miRSystem: An Integrated System for Characterizing Enriched Functions and Pathways of MicroRNA Targets , 2012, PloS one.

[27]  P. Karakousis,et al.  Exosomes Isolated from Mycobacteria-Infected Mice or Cultured Macrophages Can Recruit and Activate Immune Cells In Vitro and In Vivo , 2012, The Journal of Immunology.

[28]  S. Hüttelmaier,et al.  IGF2BP1: a post-transcriptional "driver" of tumor cell migration. , 2012, Cell adhesion & migration.

[29]  K. Drescher,et al.  Exosomal miRNAs: Biological Properties and Therapeutic Potential , 2012, Front. Gene..

[30]  X. Chen,et al.  Secreted microRNAs: a new form of intercellular communication. , 2012, Trends in cell biology.

[31]  Achilleas S. Frangakis,et al.  Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs , 2012, Nature Cell Biology.

[32]  R. Singer,et al.  IGF2BP1 promotes cell migration by regulating MK5 and PTEN signaling. , 2012, Genes & development.

[33]  K. Moore,et al.  The neuroimmune guidance cue netrin-1 promotes atherosclerosis by inhibiting macrophage emigration from plaques , 2011, Nature Immunology.

[34]  Paul J. Harrison,et al.  Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis , 2011, Nanomedicine : nanotechnology, biology, and medicine.

[35]  A. Gabrielsen,et al.  Correlations between clinical variables and gene-expression profiles in carotid plaque instability. , 2011, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[36]  Clotilde Théry,et al.  Exosome Secretion: Molecular Mechanisms and Roles in Immune Responses , 2011, Traffic.

[37]  T. Lehtimäki,et al.  miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study. , 2011, Atherosclerosis.

[38]  Aaron N. Chang,et al.  Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. , 2011, The Journal of clinical investigation.

[39]  K. Moore,et al.  Macrophages in the Pathogenesis of Atherosclerosis , 2011, Cell.

[40]  W. Shen,et al.  MiR‐146a inhibits oxidized low‐density lipoprotein‐induced lipid accumulation and inflammatory response via targeting toll‐like receptor 4 , 2011, FEBS letters.

[41]  Luigi Biancone,et al.  Exosomes/microvesicles as a mechanism of cell-to-cell communication. , 2010, Kidney international.

[42]  Jae Heun Lee,et al.  PTEN differentially regulates expressions of ICAM-1 and VCAM-1 through PI3K/Akt/GSK-3β/GATA-6 signaling pathways in TNF-α-activated human endothelial cells. , 2010, Atherosclerosis.

[43]  E. Leithe,et al.  Regulation of gap junction intercellular communication by the ubiquitin system. , 2010, Cellular signalling.

[44]  Egil Lien,et al.  NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals , 2010, Nature.

[45]  Jing Li,et al.  Secreted monocytic miR-150 enhances targeted endothelial cell migration. , 2010, Molecular cell.

[46]  K. Moore,et al.  MiR-33 Contributes to the Regulation of Cholesterol Homeostasis , 2010, Science.

[47]  M. Quinones,et al.  CCR2 Plays a Critical Role in Dendritic Cell Maturation: Possible Role of CCL2 and NF-κB , 2010, The Journal of Immunology.

[48]  Y. Matsuki,et al.  Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells*♦ , 2010, The Journal of Biological Chemistry.

[49]  K. Moore,et al.  NLRP3 inflamasomes are required for atherogenesis and activated by cholesterol crystals that form early in disease , 2010, Nature.

[50]  M. Hristov,et al.  Delivery of MicroRNA-126 by Apoptotic Bodies Induces CXCL12-Dependent Vascular Protection , 2009, Science Signaling.

[51]  R. Silverstein,et al.  CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima. , 2008, The Journal of clinical investigation.

[52]  B. Gelfand,et al.  Endothelial Cell PECAM-1 Promotes Atherosclerotic Lesions in Areas of Disturbed Flow in ApoE-Deficient Mice , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[53]  G. Randolph.  Emigration of monocyte-derived cells to lymph nodes during resolution of inflammation and its failure in atherosclerosis , 2008, Current opinion in lipidology.

[54]  T. Bisogno.  Endogenous Cannabinoids: Structure and Metabolism , 2008, Journal of neuroendocrinology.

[55]  F. Castellino,et al.  Exosomes released from macrophages infected with intracellular pathogens stimulate a proinflammatory response in vitro and in vivo. , 2007, Blood.

[56]  C. Denef.  Paracrinicity: The Story of 30 Years of Cellular Pituitary Crosstalk , 2007, Journal of neuroendocrinology.

[57]  A. Pause,et al.  The RNA-Binding Protein HuR Promotes Cell Migration and Cell Invasion by Stabilizing the β-actin mRNA in a U-Rich-Element-Dependent Manner , 2007, Molecular and Cellular Biology.

[58]  J. Lötvall,et al.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.

[59]  Qing Wang,et al.  Stabilization of Snail by HuR in the process of hydrogen peroxide induced cell migration. , 2007, Biochemical and biophysical research communications.

[60]  Sascha Keller,et al.  Exosomes: from biogenesis and secretion to biological function. , 2006, Immunology letters.

[61]  J Ratajczak,et al.  Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication , 2006, Leukemia.

[62]  D. Baltimore,et al.  NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses , 2006, Proceedings of the National Academy of Sciences.

[63]  D. Lawrence,et al.  A specific role of integrin Mac-1 in accelerated macrophage efflux to the lymphatics. , 2005, Blood.

[64]  E. Fisher,et al.  Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[65]  George Kuriakose,et al.  The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages , 2003, Nature Cell Biology.

[66]  M. Ratajczak,et al.  Numerous growth factors, cytokines, and chemokines are secreted by human CD34(+) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. , 2001, Blood.

[67]  W. Kuziel,et al.  Cc Chemokine Receptor (Ccr)2 Is Required for Langerhans Cell Migration and Localization of T Helper Cell Type 1 (Th1)-Inducing Dendritic Cells , 2000, The Journal of experimental medicine.

[68]  W. Ling,et al.  High Affinity Saturable Uptake of Oxidized Low Density Lipoprotein by Macrophages from Mice Lacking the Scavenger Receptor Class A Type I/II* , 1997, The Journal of Biological Chemistry.

[69]  C. Haslett,et al.  In vivo fate of the inflammatory macrophage during the resolution of inflammation: inflammatory macrophages do not die locally, but emigrate to the draining lymph nodes. , 1996, Journal of immunology.

[70]  S. Singer.  Intercellular communication and cell-cell adhesion. , 1992, Science.

[71]  Maire Peters,et al.  Comparison of serum exosome isolation methods for microRNA profiling. , 2014, Clinical biochemistry.

[72]  GabriellePaulsson-Berne,et al.  Profiling of Atherosclerotic Lesions by Gene and Tissue Microarrays Reveals PCSK6 as a Novel Protease in Unstable Carotid Atherosclerosis , 2013 .

[73]  K. Moore,et al.  The neuroimmune guidance cue netrin-1 promotes atherosclerosis by inhibiting the emigration of macrophages from plaques , 2012 .

[74]  Carl Nathan,et al.  Nonresolving Inflammation , 2010, Cell.

[75]  Aldons J. Lusis,et al.  Atherosclerosis : Vascular biology , 2000 .